WHO ICTRP trial

A trial investigating stem cell transplants from mismatched donors in patients…

EUCTR2011-005889-38-GB · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2011-005889-38-GB
Public title A trial investigating stem cell transplants from mismatched donors in patients with blood and bone marrow cancers
Scientific title A UK multicentre phase II study of haploidentical stem cell transplantation in patients with haematological malignancies - UK Haplo v1.0
Primary sponsor University College London
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries United Kingdom
Conditions Acute myeloid leukaemia Myelodysplastic syndromes Therapy related AML or MDS Philadelphia positive Chronic Myeloid Leukaemia Acute lymphoblastic leukaemia Non-Hodgkin's lymphoma (follicular lymphoma, mantle cell lymphoma, high grade…
Interventions Product Name: Cyclophosphamide Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: Cyclophosphamide CAS Number: 50-18-0 Concentration unit: g gram(s) Concentration type: equal Concentration number: 1-
Registration date Oct 7, 2012
Target size 78
Secondary IDs UCL/10/0411;NCT01597219
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations